This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Trigonella foenum-graecum (leaf)
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
Consult your healthcare provider before use.
South Asian and Middle Eastern fenugreek leaves used as a food and medicine; the leaf has different properties from the seed, used for diabetes, lactation, and as a vegetable.
South Asian and Middle Eastern fenugreek leaves used as a food and medicine; the leaf has different properties from the seed, used for diabetes, lactation, and as a vegetable. Key active compounds include trigonelline, diosgenin, galactomannan.
trigonelline, along with diosgenin and galactomannan, are the primary bioactive compounds in Fenugreek Leaf. These compounds modulates NF-κB and COX-2 inflammatory pathways, provides free radical scavenging activity.
Galactagogue effects
Supported by clinical evidence; more large-scale trials would strengthen findings
Antidiabetic activity
Supported by clinical evidence; more large-scale trials would strengthen findings
Anti-inflammatory properties
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Antioxidant support
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Lactation support
Based on traditional use; clinical evidence limited
Diabetes management
Based on traditional use; clinical evidence limited
Digestive conditions
Based on traditional use; clinical evidence limited
Nutritive food
Based on traditional use; clinical evidence limited
Found an error or have a correction for Fenugreek Leaf?
Report an Issue →